Company intelligence / Profile preview

Optellum

Oxford, England, United Kingdom

Ownership: Private
Development stage: Commercial

Overview

Optellum’s AI-powered Virtual Nodule Clinic is FDA-cleared, CE-MDR certified in the EU, and UKCA marked in the UK. Clinical trials and real-world deployments have demonstrated its ability to improve early lung cancer diagnosis by helping physicians identify at-risk patients sooner, reduce unnecessary invasive procedures for benign lesions, and optimize patient care pathways. The platform is commercially deployed in leading healthcare systems across the US and UK.

Therapeutic areas: OncologyPulmonology
Modalities: Device (AI-enabled clinical decision support software)Non-pharmacological therapy (decision-support, not a drug or biologic)
Industry: Medical Imaging

Partnerships

GE HealthcareJohnson & Johnson’s Lung Cancer InitiativeBristol Myers Squibb

Beyond the preview

Go deeper on Optellum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optellum.

Explore the full profile